Your browser doesn't support javascript.
loading
Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to aids treatment
Nunn, Amy S; Fonseca, Elize M; Gruskin, Sofia; Salomon, Joshua A Bastos, Francisco I.
Afiliação
  • Nunn, Amy S; Harvard School of Public Health. Department of Population and International Health. Massachusetts. US
  • Fonseca, Elize M; Oswaldo Cruz Foundation. Department of Health Information. Rio de Janeiro. BR
  • Gruskin, Sofia; Harvard School of Public Health. Bastos, Francisco I. Department of Population and International Health. BR
  • Salomon, Joshua A Bastos, Francisco I; Harvard School of Public Health. Department of Population and International Health. Massachusetts. US
PloS med ; 4(11): e305, Nov. 13, 2007. ilus, tab
Article em En | ColecionaSUS | ID: biblio-945544
Biblioteca responsável: BR1.1
ABSTRACT
Little is known about the long-term drug costs associated with treating AIDS in developing countries.Brazil’s AIDS treatment program has been cited widely as the developing world’s largest and mostsuccessful AIDS treatment program. The program guarantees free access to highly active antiretroviraltherapy (HAART) for all people living with HIV/AIDS in need of treatment. Brazil produces non-patentedgeneric antiretroviral drugs (ARVs), procures many patented ARVs with negotiated price reductions, andrecently issued a compulsory license to import one patented ARV. In this study, we investigate the driversof recent ARV cost trends in Brazil through analysis of drug-specific prices and expenditures between 2001and 2005.
Assuntos
Texto completo: 1 Coleções: 06-national / BR Base de dados: ColecionaSUS Assunto principal: Síndrome da Imunodeficiência Adquirida / Custos de Medicamentos / Terapia Antirretroviral de Alta Atividade / Antirretrovirais / Programas Nacionais de Saúde Tipo de estudo: Health_economic_evaluation Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: PloS med Ano de publicação: 2007 Tipo de documento: Article
Texto completo: 1 Coleções: 06-national / BR Base de dados: ColecionaSUS Assunto principal: Síndrome da Imunodeficiência Adquirida / Custos de Medicamentos / Terapia Antirretroviral de Alta Atividade / Antirretrovirais / Programas Nacionais de Saúde Tipo de estudo: Health_economic_evaluation Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: PloS med Ano de publicação: 2007 Tipo de documento: Article